LKB-1/STK11 loss sensitizes pancreatic tumor cells to DNA methylation and inhibition of serine biosynthesis, and thus connecting cancer metabolism to DNA methylation and tumorigenesis [20]. This evidence concerns the gene STK11 and pancreatic neoplasm.